Hubei Jumpcan Pharmaceutical Co., Ltd.
600566
Peringkat dalam Saham
#4334
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the... Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
Harga Saham
$3.87
Kapitalisasi Pasar
$3.57B
Perubahan (1 hari)
-1.64%
Perubahan (1 tahun)
9.08%
Negara
CN
Perdagangan Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Kategori
Healthcare
Pendapatan untuk Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Pendapatan pada Oct 2026 TTM: 0
Menurut laporan keuangan terbaru dari Hubei Jumpcan Pharmaceutical Co., Ltd., pendapatan saat ini (TTM) adalah 0. Pada tahun 2026, perusahaan menghasilkan pendapatan sebesar 0 sama dengan pendapatan pada tahun 2026 yang sebesar 0. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Hubei Jumpcan Pharmaceutical Co., Ltd. dari 2001 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Mengubah |
|---|---|---|
| 2025 | $888.83M | -19.07% |
| 2024 | $1.10B | -19.47% |
| 2023 | $1.36B | 4.58% |
| 2022 | $1.30B | 8.64% |
| 2021 | $1.20B | 27.21% |
| 2020 | $943.71M | -5.31% |
| 2019 | $996.65M | -4.89% |
| 2018 | $1.05B | 20.84% |
| 2017 | $867.17M | 28.71% |
| 2016 | $673.77M | 16.12% |
| 2015 | $580.22M | 20.34% |
| 2014 | $482.15M | 19.49% |
| 2013 | $403.51M | 31.04% |
| 2012 | $307.92M | 707.24% |
| 2011 | $38.14M | 6.17% |
| 2010 | $35.93M | 10.48% |
| 2009 | $32.52M | 4.19% |
| 2008 | $31.21M | 4.28% |
| 2007 | $29.93M | 16.41% |
| 2006 | $25.71M | 17.82% |
| 2005 | $21.82M | 23.58% |
| 2004 | $17.66M | 28.84% |
| 2003 | $13.71M | 5.73% |
| 2002 | $12.96M | -5.87% |
| 2001 | $13.77M | 0.00% |
Pendapatan untuk perusahaan serupa atau pesaing
| Perusahaan | Pendapatan | Perbedaan Pendapatan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
